Quercetin Combo Extends C. elegans Lifespan 24% Through FOXO and Nrf2 Pathways
A novel quercetin derivative and polyphenol blend extended worm lifespan by up to 24% and protected neurons from toxic damage.
Summary
Researchers tested quercetin, luteolin, and a lesser-known compound called 3-O-methylquercetin — alone and combined — in the roundworm C. elegans. The combination extended lifespan by 20–24%, improved movement, reduced aging markers like lipofuscin buildup, and protected against neurotoxin-induced damage. These effects worked through two well-known longevity regulators — FOXO (DAF-16) and Nrf2 (SKN-1) — but bypassed the insulin-signaling pathway (DAF-2/IGF1R), suggesting a distinct mechanism. The findings position 3-O-methylquercetin as a promising anti-aging and neuroprotective compound, particularly in combination with other polyphenols.
Detailed Summary
Polyphenols found in plant foods have long been associated with health benefits, but their mechanisms in aging biology are still being mapped. This study from Brazil's Federal University of Rio Grande do Sul focused on a relatively understudied quercetin derivative — 3-O-methylquercetin (3OMQ) — and explored whether it could enhance longevity and neuroprotection, especially in combination with quercetin and luteolin.
Using the roundworm Caenorhabditis elegans, a gold-standard model in longevity research, the team exposed wild-type and genetically mutant worms to each compound individually and as a formulation (FORM). They then measured lifespan, physical motility, cellular senescence markers, and resistance to neurotoxins including methylmercury and manganese.
Both 3OMQ alone and the full combination extended lifespan by 20–24% and improved movement with age. Crucially, these effects were abolished in worms lacking DAF-16 (the FOXO homolog) or SKN-1 (the Nrf2 homolog), confirming pathway dependency. Notably, the benefits were independent of DAF-2, the insulin/IGF-1 receptor — suggesting a mechanism distinct from caloric restriction mimetics. Both compounds also triggered nuclear translocation of DAF-16 and upregulated SKN-1 expression, directly activating these longevity regulators.
On the neuroprotection front, 3OMQ and FORM reduced neurodegeneration and cholinesterase hyperactivity following exposure to methylmercury and manganese — both environmental neurotoxins linked to neurological disease.
For clinicians and health-conscious individuals, these findings reinforce the value of flavonoid diversity in diet and supplementation. The synergistic effects of combining structurally similar polyphenols may be greater than any single compound alone.
Important caveats apply: this study was conducted entirely in C. elegans, a model with significant physiological distance from humans. The summary is based on the abstract only, and translation to mammalian or clinical outcomes remains to be demonstrated.
Key Findings
- 3-O-methylquercetin alone extended C. elegans lifespan by 20–24% versus controls.
- A polyphenol combination (quercetin + luteolin + 3OMQ) matched or exceeded single-compound lifespan gains.
- Effects required DAF-16/FOXO and SKN-1/Nrf2 but were independent of insulin/IGF-1 signaling.
- Both 3OMQ and the combination reduced neurotoxin-induced neurodegeneration and cholinesterase hyperactivity.
- Compounds reduced lipofuscin accumulation, a key biomarker of cellular aging.
Methodology
The study used Caenorhabditis elegans wild-type and mutant strains (daf-2, daf-16, skn-1) to test compounds individually and in combination. Outcomes included lifespan curves, motility assays, senescence biomarkers, and neurotoxin challenge models using PTZ, methylmercury, and manganese. Pathway dependence was confirmed through genetic knockouts.
Study Limitations
This study was conducted exclusively in C. elegans, a simple invertebrate model with limited direct applicability to human aging or neurological disease. No mammalian or clinical data are available to support translation of these findings. Additionally, this summary is based on the abstract only, as the full paper was not accessible, which limits assessment of methodology, dosing, and statistical rigor.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.